Condition
Squamous Cell Carcinoma of Oral Cavity
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 2 (2)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05312710Phase 2Active Not Recruiting
Safety and Efficacy of APG-157 in Head and Neck Cancer
NCT05144698Phase 1Recruiting
RAPA-201 Therapy of Solid Tumors
NCT05992610Not ApplicableRecruitingPrimary
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT03923998Early Phase 1CompletedPrimary
Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers
NCT03121313Phase 2UnknownPrimary
Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
Showing all 5 trials